Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Appl Microbiol Biotechnol ; 104(3): 1201-1209, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31900564

RESUMEN

We developed a genetic approach to efficiently add an affinity tag to every copy of protein IX (pIX) of M13 filamentous bacteriophage in a population. Affinity-tagged phages can be immobilized on a surface in a uniform monolayer in order to position the pIII-displayed peptides or proteins for optimal interaction with ligands. The tagging consists of two major steps. First, gene IX (gIX) of M13 phage is mutated in Escherichia coli via genetic recombineering with the gIX::aacCI insertion allele. Second, a plasmid that co-produces the affinity-tagged pIX and native pVIII is transformed into the strain carrying the defective M13 gIX. This genetic complementation allows the formation of infective phage particles that carry a full complement (five copies per virion) of the affinity-tagged pIX. To demonstrate the efficacy of our method, we tagged a M13 derivative phage, M13KE, with Strep-tag II. In order to tag pIX with Strep-tag II, the phage genes for pIX and pVIII were cloned and expressed from pASG-IBA4 which contains the E. coli OmpA signal sequence and Strep-Tag II under control of the tetracycline promoter/operator system. We achieved the maximum phage production of 3 × 1011 pfu/ml when Strep-Tag II-pIX-pVIII fusion was induced with 10 ng/ml of anhydrotetracycline. The complete process of affinity tagging a phage probe takes less than 5 days and can be utilized to tag any M13 or fd pIII-displayed oligopeptide probes to improve their performance.


Asunto(s)
Bacteriófago M13/genética , Proteínas de la Cápside/genética , Técnicas de Visualización de Superficie Celular/métodos , Escherichia coli/genética , Ácidos Nucleicos Inmovilizados , Clonación Molecular , Mutación , Oligopéptidos , Biblioteca de Péptidos , Plásmidos/genética , Señales de Clasificación de Proteína/genética
2.
Microbiology (Reading) ; 164(4): 551-562, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29533746

RESUMEN

Pseudomonas aeruginosa causes acute and chronic human infections and is the major cause of morbidity and mortality in cystic fibrosis (CF) patients. We previously determined that the sn-glycerol-3-phosphate dehydrogenase encoded by glpD plays a larger role in P. aeruginosa physiology beyond its role in glycerol metabolism. To better understand the effect of a glpD mutation on P. aeruginosa physiology we compared the transcriptomes of P. aeruginosa strain PAO1 and the PAO1ΔglpD mutant using RNA-seq analysis. We determined that a null mutation of glpD significantly altered amino acid metabolism in P. aeruginosa and affected the production of intermediates that are channelled into the tricarboxylic acid cycle. Moreover, the loss of glpD induced a general stress response mediated by RpoS in P. aeruginosa. Several other phenotypes observed for the P. aeruginosa glpD mutant include increased persister cell formation, reduced extracellular ATP accumulation and increased heat output. Taken together, these findings implicate sn-glycerol-3-phosphate dehydrogenase as a key player in energy metabolism in P. aeruginosa.


Asunto(s)
Proteínas Bacterianas/metabolismo , Metabolismo Energético/genética , Perfilación de la Expresión Génica , Regulación Bacteriana de la Expresión Génica , Glicerolfosfato Deshidrogenasa/metabolismo , Pseudomonas aeruginosa/genética , Proteínas Bacterianas/genética , Eliminación de Gen , Glicerolfosfato Deshidrogenasa/genética , Redes y Vías Metabólicas/genética , Fenotipo , Pseudomonas aeruginosa/metabolismo , Estrés Fisiológico/genética
3.
J Antimicrob Chemother ; 70(8): 2228-33, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25921515

RESUMEN

OBJECTIVES: The purpose of this study was to describe a putative role for a novel soxS mutation in contributing to multiple-antibiotic resistance in canine fluoroquinolone-associated MDR (FQ-MDR) Escherichia coli. This soxS mutation was discovered in canine faecal E. coli isolates during a study investigating the effect of oral fluoroquinolone administration on faecal E. coli in healthy dogs. METHODS: We determined via quantitative real-time RT-PCR that both soxS and acrB were overexpressed in the clinical soxS Ala-12→Ser (soxS(A12S)) mutants and this may account for their FQ-MDR phenotype. We validated the FQ-MDR phenotype of the clinical isolates by reconstructing the WT and the soxS(A12S) mutation in the E. coli soxS null mutant JW4023 (soxS::kn) via allelic exchange. RESULTS: The JW4023 soxS(A12S) derivative showed an increase in MICs of ciprofloxacin, enrofloxacin and chloramphenicol compared with the JW4023 derivative in which the WT soxS had been restored. The soxS and acrB genes were overexpressed in the JW4023 soxS(A12S) mutant compared with JW4023 with WT soxS. A similar overexpression of efflux pump genes and an increase in antibiotic resistance were observed upon stimulation with paraquat to resemble the phenotype of the clinical soxS(A12S) isolates. CONCLUSIONS: Our data suggest that the soxS(A12S) substitution mutation is selected in clinical isolates when dogs are exposed to a fluoroquinolone and that this mutation contributes to the FQ-MDR phenotype of E. coli isolates.


Asunto(s)
Sustitución de Aminoácidos , Farmacorresistencia Bacteriana Múltiple , Proteínas de Escherichia coli/genética , Escherichia coli/efectos de los fármacos , Regulación Bacteriana de la Expresión Génica , Mutación Missense , Transactivadores/genética , Alanina/genética , Animales , Transporte Biológico Activo , Perros , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/veterinaria , Proteínas de Escherichia coli/biosíntesis , Heces/microbiología , Perfilación de la Expresión Génica , Prueba de Complementación Genética , Pruebas de Sensibilidad Microbiana , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/biosíntesis , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Recombinación Genética , Selección Genética , Serina/genética , Transactivadores/biosíntesis
4.
J Bacteriol ; 196(13): 2491-8, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24769699

RESUMEN

Methyl-coenzyme M reductase (MCR) catalyzes the reversible reduction of methyl-coenzyme M (CH3-S-CoM) and coenzyme B (HS-CoB) to methane and heterodisulfide CoM-S-S-CoB (HDS). MCR contains the hydroporphinoid nickel complex coenzyme F430 in its active site, and the Ni center has to be in its Ni(I) valence state for the enzyme to be active. Until now, no in vitro method that fully converted the inactive MCRsilent-Ni(II) form to the active MCRred1-Ni(I) form has been described. With the potential use of recombinant MCR in the production of biofuels and the need to better understand this enzyme and its activation process, we studied its activation under nonturnover conditions and achieved full MCR activation in the presence of dithiothreitol and protein components A2, an ATP carrier, and A3a. It was found that the presence of HDS promotes the inactivation of MCRred1, which makes it essential that the activation process is isolated from the methane formation assay, which tends to result in minimal activation rates. Component A3a is a multienzyme complex that includes the mcrC gene product, an Fe-protein homolog, an iron-sulfur flavoprotein, and protein components involved in electron bifurcation. A hypothetical model for the cellular activation process of MCR is presented.


Asunto(s)
Regulación Bacteriana de la Expresión Génica/fisiología , Methanobacteriaceae/enzimología , Oxidorreductasas/metabolismo , Secuencia de Aminoácidos , Clonación Molecular , Ditiotreitol , Activación Enzimática/fisiología , Proteínas Hierro-Azufre/genética , Proteínas Hierro-Azufre/metabolismo , Methanobacteriaceae/genética , Methanobacteriaceae/metabolismo , Datos de Secuencia Molecular , Oxidorreductasas/genética
5.
Can J Microbiol ; 58(11): 1288-94, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23145826

RESUMEN

Escherichia coli respond to selective pressure of antimicrobial therapy by developing resistance through a variety of mechanisms. The purpose of this study was to characterize the genetic mechanisms of antimicrobial resistance in fecal E. coli after the routine use of 2 popular antimicrobials. Fourteen resistant E. coli isolates, representing predominant clones that emerged in healthy dogs' feces after treatment with either amoxicillin (11 E. coli isolates) or enrofloxacin (3 E. coli isolates), were tested for mutations in DNA gyrase (gyrA and gyrB) and in topoisomerase IV (parC) and for the presence of ß-lactamases (bla(TEM), bla(SHV), bla(PSE-1) and bla(CTX-M)) and plasmid-mediated quinolone resistance (qnrA, qnrB, qnrS, aac(6')-Ib, and qepA), by polymerase chain reaction. Escherichia coli isolates cultured following amoxicillin therapy only expressed single-drug resistance to ß-lactams, while the isolates cultured from dogs receiving enrofloxacin therapy expressed multidrug resistance (MDR). The use of RND efflux pump inhibitors increased the susceptibility of the 3 MDR E. coli isolates to doxycycline, chloramphenicol, enrofloxacin, and ciprofloxacin, which indicates a role of the efflux pump in the acquisition of the MDR phenotype. Amplification and sequencing of AcrAB efflux pump regulators (soxR, soxS, marR, and acrR) revealed only the presence of a single mutation in soxS in the 3 MDR isolates.


Asunto(s)
Amoxicilina/farmacología , Antibacterianos/farmacología , Farmacorresistencia Microbiana/genética , Heces/microbiología , Fluoroquinolonas/farmacología , Amoxicilina/administración & dosificación , Animales , Girasa de ADN/genética , Topoisomerasa de ADN IV/genética , Perros , Farmacorresistencia Microbiana/efectos de los fármacos , Enrofloxacina , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Proteínas de Escherichia coli/genética , Fluoroquinolonas/administración & dosificación , Transferencia de Gen Horizontal , Mutación , Plásmidos/genética , Reacción en Cadena de la Polimerasa , beta-Lactamasas/genética , beta-Lactamas/farmacología
6.
Can J Microbiol ; 57(3): 186-95, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21358759

RESUMEN

Pseudomonas aeruginosa causes chronic pulmonary infections, which can persist for decades, in patients with cystic fibrosis (CF). Current evidence suggests that the glyoxylate pathway is an important metabolic pathway for P. aeruginosa growing within the CF lung. In this study, we identified glcB, which encodes for the second key enzyme of the glyoxylate pathway, malate synthase, as a requirement for virulence of P. aeruginosa on alfalfa seedlings. While expression of glcB in PAO1, an acute isolate of P. aeruginosa, responds to some carbon sources that use the glyoxylate pathway, expression of glcB in FRD1, a CF isolate, is constitutively upregulated. Malate synthase activity is moderately affected by glcB expression and is nearly constitutive in both backgrounds, with slightly higher activity in FRD1 than in PAO1. In addition, RpoN negatively regulates glcB in PAO1 but not in FRD1. In summary, the genes encoding for the glyoxylate-specific enzymes appear to be coordinately regulated, even though they are not located within the same operon on the P. aeruginosa genome. Furthermore, both genes encoding for the glyoxylate enzymes can become deregulated during adaptation of the bacterium to the CF lung.


Asunto(s)
Proteínas Bacterianas/metabolismo , Regulación Bacteriana de la Expresión Génica , Malato Sintasa/metabolismo , Pseudomonas aeruginosa/enzimología , Proteínas Bacterianas/genética , Carbono/metabolismo , Represión Catabólica , ADN Bacteriano/genética , Glioxilatos/metabolismo , Malato Sintasa/genética , Medicago sativa/microbiología , Mutación , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/patogenicidad , Virulencia
7.
PLoS One ; 16(6): e0252970, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34133429

RESUMEN

Pseudomonas aeruginosa secretes several endopeptidases, including elastase, alkaline proteinase (Apr), a lysine-specific endopeptidase (LysC), and an aminopeptidase (PaAP), all of which are important virulence factors. Activation of the endopeptidases requires removal of an inhibitory N-terminal propeptide. Activation of pro-PaAP, in contrast, requires C-terminal processing. The activating proteases of pro-PaAP and their cleavage site(s) have not yet been defined. Studying pro-PaAP processing in a wild type P. aeruginosa strain and strains lacking either elastase or both elastase and Apr, we detected three processing variants, each ~56 kDa in size (AP56). Activity assays and N- and C-terminal sequence analyses of these variants pointed at LysC as the principal activating protease, cleaving a Lys512-Ala513 peptide bond at the C-terminal end of pro-PaAP. Elastase and/or Apr are required for activation of LysC, suggesting both are indirectly involved in activation of PaAP. To shed light on the function(s) of the N-terminal domain of AP56, we purified recombinant AP56 and generated from it the 28 kDa catalytic domain (AP28). The kinetic constants (Km and Kcat) for hydrolysis of Leu-, Lys-, Arg- and Met-p-nitroanilide (pNA) derivatives by AP56 and AP28 were then determined. The catalytic coefficients (Kcat/Km) for hydrolysis of all four substrates by AP28 and AP56 were comparable, indicating that the non-catalytic domain is not involved in hydrolysis of small substrates. It may, however, regulate hydrolysis of natural peptides/proteins. Lys-pNA was hydrolyzed 2 to 3-fold more rapidly than Leu-pNA and ~8-fold faster than Arg- or Met-pNA, indicating that Lys-pNA was the preferred substrate.


Asunto(s)
Aminopeptidasas/metabolismo , Metaloendopeptidasas/metabolismo , Elastasa Pancreática/metabolismo , Proteolisis , Pseudomonas aeruginosa/enzimología , Secuencia de Aminoácidos , Aminopeptidasas/genética , Dominio Catalítico , Hidrólisis , Cinética , Metaloendopeptidasas/genética , Elastasa Pancreática/genética , Dominios Proteicos , Pseudomonas aeruginosa/crecimiento & desarrollo , Especificidad por Sustrato
8.
Microbiology (Reading) ; 156(Pt 4): 1201-1210, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20093293

RESUMEN

Pseudomonas aeruginosa is the major aetiological agent of chronic pulmonary infections in patients with cystic fibrosis (CF). The metabolic pathways utilized by P. aeruginosa during these infections, which can persist for decades, are poorly understood. Several lines of evidence suggest that the glyoxylate pathway, which utilizes acetate or fatty acids to replenish intermediates of the tricarboxylic acid cycle, is an important metabolic pathway for P. aeruginosa adapted to the CF lung. Isocitrate lyase (ICL) is one of two major enzymes of the glyoxylate pathway. In a previous study, we determined that P. aeruginosa is dependent upon aceA, which encodes ICL, to cause disease on alfalfa seedlings and in rat lungs. Expression of aceA in PAO1, a P. aeruginosa isolate associated with acute infection, is regulated by carbon sources that utilize the glyoxyate pathway. In contrast, expression of aceA in FRD1, a CF isolate, is constitutively upregulated. Moreover, this deregulation of aceA occurs in other P. aeruginosa isolates associated with chronic infection, suggesting that high ICL activity facilitates adaptation of P. aeruginosa to the CF lung. Complementation of FRD1 with a PAO1 clone bank identified that rpoN negatively regulates aceA. However, the deregulation of aceA in FRD1 was not due to a knockout mutation of rpoN. Regulation of the glyoxylate pathway by RpoN is likely to be indirect, and represents a unique regulatory role for this sigma factor in bacterial metabolism.


Asunto(s)
Proteínas Bacterianas/metabolismo , Isocitratoliasa/metabolismo , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/enzimología , Factor sigma/metabolismo , Proteínas Bacterianas/genética , Fibrosis Quística/microbiología , Regulación hacia Abajo , Regulación Enzimológica de la Expresión Génica , Glioxilatos/metabolismo , Humanos , Isocitratoliasa/genética , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/metabolismo , Factor sigma/genética
9.
Microbiology (Reading) ; 155(Pt 11): 3599-3610, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19684067

RESUMEN

Myxococcus xanthus, a Gram-negative soil bacterium, undergoes multicellular development when nutrients become limiting. Aggregation, which is part of the developmental process, requires the surface motility of this organism. One component of M. xanthus motility, the social (S) gliding motility, enables the movement of cells in close physical proximity. Previous studies demonstrated that the cell surface-associated exopolysaccharide (EPS) is essential for S motility and that the Dif proteins form a chemotaxis-like pathway that regulates EPS production in M. xanthus. DifA, a homologue of methyl-accepting chemotaxis proteins (MCPs) in the Dif system, is required for EPS production, S motility and development. In this study, a spontaneous extragenic suppressor of a difA deletion was isolated in order to identify additional regulators of EPS production. The suppressor mutation was found to be a single base pair insertion in cheW7 at the che7 chemotaxis gene cluster. Further examination indicated that mutations in cheW7 may lead to the interaction of Mcp7 with DifC (CheW-like) and DifE (CheA-like) to reconstruct a functional pathway to regulate EPS production in the absence of DifA. In addition, the cheW7 mutation was found to partially suppress a pilA mutation in EPS production in a difA(+) background. Further deletion of difA from the pilA cheW7 double mutant resulted in a triple mutant that produced wild-type levels of EPS, implying that DifA (MCP-like) and Mcp7 compete for interactions with DifC and DifE in the modulation of EPS production.


Asunto(s)
Proteínas Bacterianas/metabolismo , Myxococcus xanthus/genética , Polisacáridos Bacterianos/biosíntesis , Supresión Genética , Proteínas Bacterianas/genética , Quimiotaxis/genética , Regulación Bacteriana de la Expresión Génica , Familia de Multigenes , Mutagénesis Insercional , Myxococcus xanthus/metabolismo , ARN Bacteriano/genética
10.
Microb Drug Resist ; 25(4): 509-519, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30457926

RESUMEN

Background: An increasing pattern of fluoroquinolone resistance (FQR) among bacterial pathogens has been described worldwide. In this study, we compared the patterns of genetic mechanisms that confer FQR for Escherichia coli and Klebsiella pneumoniae isolated from the Assiut University Hospitals in Egypt. Methods: Eighty-seven clinical E. coli and K. pneumoniae isolates were tested for mutations in gyrA, gyrB, parC, and parE genes by polymerase chain reaction (PCR) amplification and DNA sequencing. The presence of plasmid-mediated quinolone resistance (PMQR) genes qnrA, qnrB, qnrS, aac(6')-Ib, qepA was screened by PCR and characterized by conjugation. Correlations between different FQR mechanisms and ciprofloxacin minimal inhibitory concentration (MIC) levels were determined. Results: A higher number of quinolone resistance-determining region (QRDR) mutations was detected in E. coli, while the number of PMQR determinants was significantly higher in K. pneumoniae. However, K. pneumoniae showed stronger correlations than E. coli between MIC levels and number of mutations in the QRDR per isolate (rs = 0.8, p < 0.0001 and rs = 0.7, p < 0.0001, respectively) as well as between MIC levels and number of plasmids (rs = 0.4, p = 0.005 and rs = 0.3, p = 0.02, respectively). Conclusions: Although we observed a prevalence of chromosomal mutations for E. coli and the presence of plasmid-encoded genes for K. pneumoniae that resulted in FQR phenotype, high levels of FQR appeared to occur as a result of gradual accumulation of mutations in QRDR for both bacteria. To our best of knowledge, this is the first study to report and compare the correlation between FQ MIC levels and different genetic mechanisms for FQR in Enterobacteriaceae.


Asunto(s)
Farmacorresistencia Bacteriana/efectos de los fármacos , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Escherichia coli/efectos de los fármacos , Fluoroquinolonas/farmacología , Klebsiella pneumoniae/efectos de los fármacos , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Ciprofloxacina/farmacología , Girasa de ADN/genética , Topoisomerasa de ADN IV/genética , Farmacorresistencia Bacteriana/genética , Egipto , Infecciones por Enterobacteriaceae/microbiología , Escherichia coli/genética , Hospitales Universitarios , Humanos , Klebsiella pneumoniae/genética , Pruebas de Sensibilidad Microbiana/métodos , Plásmidos/genética , Quinolonas/farmacología
11.
Sci Rep ; 8(1): 13251, 2018 09 05.
Artículo en Inglés | MEDLINE | ID: mdl-30185933

RESUMEN

When the subterranean termite Reticulitermes flavipes is fed heat-killed methicillin resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa, the termite produces proteins with antibacterial activity against the inducer pathogen in its hemolymph. We used a proteomic approach to characterize the alterations in protein profiles caused by the inducer bacterium in the hemolymph of the termite. Nano-liquid chromatography-tandem mass spectrometry analysis identified a total of 221 proteins and approximately 70% of these proteins could be associated with biological processes and molecular functions. Challenges with these human pathogens induced a total of 57 proteins (35 in MRSA-challenged, 16 in P. aeruginosa-challenged, and 6 shared by both treatments) and suppressed 13 proteins by both pathogens. Quasi-Poisson likelihood modeling with false discovery rate adjustment identified a total of 18 and 40 proteins that were differentially expressed at least 2.5-fold in response to MRSA and P. aeruginosa-challenge, respectively. We selected 7 differentially expressed proteins and verified their gene expression levels via quantitative real-time RT-PCR. Our findings provide an initial insight into a putative termite immune response against MRSA and P. aeruginosa-challenge.


Asunto(s)
Proteínas de Insectos/metabolismo , Isópteros/microbiología , Staphylococcus aureus Resistente a Meticilina/patogenicidad , Proteómica/métodos , Pseudomonas aeruginosa/patogenicidad , Animales , Cromatografía Liquida , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Hemolinfa/metabolismo , Hemolinfa/microbiología , Inmunidad Innata , Proteínas de Insectos/genética , Isópteros/metabolismo , Nanotecnología , Espectrometría de Masas en Tándem
12.
PLoS One ; 11(9): e0162249, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27611223

RESUMEN

The emergence and dissemination of multidrug resistant bacterial pathogens necessitate research to find new antimicrobials against these organisms. We investigated antimicrobial production by eastern subterranean termites, Reticulitermes flavipes, against a panel of bacteria including three multidrug resistant (MDR) and four non-MDR human pathogens. We determined that the crude extract of naïve termites had a broad-spectrum activity against the non-MDR bacteria but it was ineffective against the three MDR pathogens Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii. Heat or trypsin treatment resulted in a complete loss of activity suggesting that antibacterial activity was proteinaceous in nature. The antimicrobial activity changed dramatically when the termites were fed with either heat-killed P. aeruginosa or MRSA. Heat-killed P. aeruginosa induced activity against P. aeruginosa and MRSA while maintaining or slightly increasing activity against non-MDR bacteria. Heat-killed MRSA induced activity specifically against MRSA, altered the activity against two other Gram-positive bacteria, and inhibited activity against three Gram-negative bacteria. Neither the naïve termites nor the termites challenged with heat-killed pathogens produced antibacterial activity against A. baumannii. Further investigation demonstrated that hemolymph, not the hindgut, was the primary source of antibiotic activity. This suggests that the termite produces these antibacterial activities and not the hindgut microbiota. Two-dimensional gel electrophoretic analyses of 493 hemolymph protein spots indicated that a total of 38 and 65 proteins were differentially expressed at least 2.5-fold upon being fed with P. aeruginosa and MRSA, respectively. Our results provide the first evidence of constitutive and inducible activities produced by R. flavipes against human bacterial pathogens.


Asunto(s)
Antibacterianos/farmacología , Proteínas de Insectos/farmacología , Isópteros/química , Acinetobacter baumannii/efectos de los fármacos , Animales , Electroforesis en Gel de Poliacrilamida , Hemolinfa/química , Humanos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa/efectos de los fármacos
13.
J Microbiol Methods ; 125: 81-6, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27089860

RESUMEN

We developed an effective and rapid assay to detect both bio-energetic and envelope permeability (BEEP) alterations of Pseudomonas aeruginosa. The assay is based on quantification of extracellular ATP in bacterial cultures using luciferase as a reporter. To demonstrate the validity of our assay we conducted a biased screen of a transposon insertion library in P. aeruginosa strain PAO1 in order to expedite the isolation of mutants with defects in bioenergetic pathways. We successfully isolated insertion mutants that were reduced for extracellular ATP accumulation and identified the corresponding mutations that caused the phenotype. Most of the genes identified from this analysis were associated with energy metabolism and several appeared to be potentially novel bioenergetic targets. In addition, we show that treatment of P. aeruginosa strain PAO1 with antibiotics that disrupt the bacterial cell envelope leads to greater extracellular ATP accumulation. In summary, increases in extracellular ATP accumulation above wild type levels indicated a perturbation of membrane permeability while decreases in extracellular ATP accumulation indicated defects in bioenergetics.


Asunto(s)
Membrana Celular/fisiología , Metabolismo Energético , Pseudomonas aeruginosa/metabolismo , Adenosina Trifosfato/análisis , Adenosina Trifosfato/metabolismo , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Membrana Celular/química , Elementos Transponibles de ADN , Luciferasas , Mutagénesis , Permeabilidad , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/fisiología
14.
J Biotechnol ; 117(1): 1-10, 2005 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-15831242

RESUMEN

The quorum-sensing (las and rhl) systems play critical roles in the pathogenicity of Pseudomonas aeruginosa and its synthesis of the important biosurfactants, rhamnolipids. In this work, P. aeruginosa PAO1 and its rhlI and rhlR null mutants were used to study the degradation and synthesis kinetics of the rhl system's autoinducer PAI2 (N-butanoyl-homoserine lactone). The two mutants, lacking the ability of synthesizing PAI2 or RhlR protein, produced insignificant amounts of rhamnolipids while having similar growth profiles as the wild-type culture. The regulatory RhlR:PAI2 complex is thus essential to rhamnolipid synthesis. In batch culture of the wild-type PAO1, the autoinducer PAI2 concentration increased along cell growth, especially during the transition from exponential-growth phase to stationary phase, and began to decrease after entering the stationary phase. The decrease in the stationary phase resulted from a faster PAI2 degradation than its synthesis. The degradation kinetics was studied using PAI2-containing supernatants (from centrifuged broth of wild-type culture) with and without the rhlI(-) mutant cells incapable of PAI2 synthesis. Being insignificant in the cell-free systems, PAI2 degradation was found predominantly cell-associated and could be described empirically by the first-order, exponential decay kinetics with the best-fit degradation constant (k(d)) of 0.195 h(-1). When similarly modeled with a first-order kinetics, PAI2 synthesis in stationary-phase wild-type culture was derived to have a synthesis constant (k(s)) of 0.189 h(-1). The PAI2 concentration in batch cultivation of the rhlR(-) mutant also showed an increase-then-decrease profile. However, the maximum PAI2 concentration was about one third of that from the wild-type culture. The constitutive rate of PAI2 synthesis was therefore significantly lower than the rate attainable with active auto-induction by RhlR-PAI2 complex.


Asunto(s)
Isomerasas Aldosa-Cetosa/metabolismo , Proteínas Bacterianas/metabolismo , Pseudomonas aeruginosa/metabolismo , Transducción de Señal , Glucolípidos/biosíntesis , Cinética , Pseudomonas aeruginosa/crecimiento & desarrollo
15.
Biotechnol J ; 10(11): 1783-91, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26110969

RESUMEN

Current existing assay systems for evaluating antimicrobial activity suffer from several limitations including excess reagent consumption and inaccurate concentration gradient preparation. Recently, microfluidic systems have been developed to provide miniaturized platforms for antimicrobial susceptibility assays. However, some of current microfluidic based assays require continuous flows of reagents or elaborate preparation steps during concentration preparation. In this study, we introduce a novel microfluidic chip based growth phenotype assay that automatically generates a logarithmic concentration gradient and allows observing the growth of pathogenic bacteria under different concentrations of antibiotics in nanoliter batch culture reactors. We chose pathogen bacterium Pseudomonas aeruginosa as a model strain and evaluated the inhibitory effects of gentamicin and ciprofloxacin. We determined the EC50 values and confirmed the validity of the present system by comparing the EC50 values obtained through conventional test tube method. We demonstrated that the EC50 values acquired from present assay are comparable to those obtained from conventional test tube cultures. The potential application of present assay system for investigating combinatorial effects of antibiotics on multidrug resistant pathogenic bacteria is discussed and it can be further used for systematic evaluation of antifungal or antiviral agents.


Asunto(s)
Antibacterianos/farmacología , Pruebas de Sensibilidad Microbiana/instrumentación , Pruebas de Sensibilidad Microbiana/métodos , Técnicas Analíticas Microfluídicas/instrumentación , Diseño de Equipo , Pseudomonas aeruginosa/efectos de los fármacos
16.
Genome Announc ; 3(2)2015 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-25792066

RESUMEN

We announce here the complete genome sequence of the Pseudomonas aeruginosa mucoid strain FRD1, isolated from the sputum of a cystic fibrosis patient. The complete genome of P. aeruginosa FRD1 is 6,712,339 bp. This genome will allow comparative genomics to be used to identify genes associated with virulence, especially those involved in chronic pulmonary infections.

17.
J Microbiol Methods ; 58(2): 203-12, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15234518

RESUMEN

To facilitate study of the opportunistic bacterial pathogen Pseudomonas aeruginosa, several genetic tools were developed. These tools include a series of cassettes carrying (a) the minimal sequence for the origin of transfer (oriT) of RP4 plasmid for introducing plasmid into P. aeruginosa via conjugation, (b) a minimal sequence for P. aeruginosa replicon (stabilizing fragment or SF) for maintenance of plasmids in P. aeruginosa, and (c) the transcriptionally non-polar tetracycline resistance gene (TcR) for insertional mutagenesis. Additional genetic constructs include (d) two conjugative and suicide lacZ reporter fusion plasmids for studying gene expression at the transcriptional or translational level, (e) a gentamicin resistant promoter-probing mini-Tn5 lacZ, and (f) a tightly regulated T7 promoter/repressor system to control gene expression in P. aeruginosa.


Asunto(s)
Técnicas Bacteriológicas , Técnicas Genéticas , Pseudomonas aeruginosa/genética , Conjugación Genética , Elementos Transponibles de ADN/genética , ADN Bacteriano/genética , Genes Reporteros , Gentamicinas/farmacología , Operón Lac , Mutagénesis Insercional , Plásmidos/genética , Regiones Promotoras Genéticas , Pseudomonas aeruginosa/efectos de los fármacos , Origen de Réplica , Resistencia a la Tetraciclina/genética
18.
J Virol Methods ; 179(1): 154-60, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22100996

RESUMEN

Potyviruses are a persistent threat to bell pepper (Capsicum annuum L.) production worldwide. Much effort has been expended to study the resistance response of pepper cultivars at whole plant levels but with only limited effort at the cellular level using protoplasts. A pepper protoplast isolation procedure is available but an inoculation procedure is needed that provides consistent and highly efficient infection. An electroporation-based procedure for inoculation of potyviruses was developed using a base procedure developed for Cucumber mosaic virus (CMV). The final parameters identified for efficient potyvirus infection of pepper protoplasts involves two 25ms pulses, 200V each pulse with a 10s interval between pulses. Depending on the method of detection, e.g., ELISA versus RT-PCR, potyvirus RNA inoculum ranged from 10 to 40µg with infection detection occurring with samples of 50,000-100,000 protoplasts.


Asunto(s)
Capsicum/virología , Cucumovirus/genética , Electroporación/métodos , Protoplastos/virología , Transfección/métodos , Virología/métodos , Cucumovirus/aislamiento & purificación
19.
J Microbiol Methods ; 78(3): 319-24, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19615413

RESUMEN

In order to facilitate genetic study of the opportunistic bacterial pathogen Pseudomonas aeruginosa, we isolated a conditional, temperature-sensitive plasmid origin of replication. We mutagenized the popular Pseudomonas stabilizing fragment from pRO1610 in vitro using the Taq thermostable DNA polymerase in a polymerase chain reaction (PCR). Out of approximately 23,000 potential clones, 48 temperature-sensitive mutants were isolated. One mutant was further characterized and the origin of replication was designated as mSF(ts1). The mutations that resulted in a temperature-sensitive phenotype in mSF(ts1) were localized to the 1.2 kb of minimum sequence required for replication in P. aeruginosa. The DNA sequence analysis revealed two mutations within the coding sequence of the Replication control (Rep) protein. Growth of P. aeruginosa carrying the temperature-sensitive plasmid at the non-permissive temperature of 42 degrees C resulted in loss of the plasmid by greater than 99.9999% of the cells after 16 h of growth. In order to facilitate its utilization, the mSF(ts1) was converted into a genetic cassette flanked by mirrored restriction endonuclease digestion sites of a pUC1918 derivative. We demonstrate utilization of the mSF(ts1) for genetic studies involving complementation and regeneration of a mutant in P. aeruginosa research.


Asunto(s)
Genética Microbiana/métodos , Mutación , Plásmidos , Pseudomonas aeruginosa/genética , Temperatura , Secuencia de Aminoácidos , Proteínas Bacterianas/genética , Secuencia de Bases , ADN Helicasas/genética , Prueba de Complementación Genética , Humanos , Datos de Secuencia Molecular , Mutagénesis , Mutación Missense , Recombinación Genética , Transactivadores/genética
20.
J Microbiol Methods ; 78(1): 10-9, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19394369

RESUMEN

Recent biological terrorism threats and outbreaks of microbial pathogens clearly emphasize the need for biosensors that can quickly and accurately identify infectious agents. The majority of rapid biosensors generate detectable signals when a molecular probe in the detector interacts with an analyte of interest. Analytes may be whole bacterial or fungal cells, virus particles, or specific molecules, such as chemicals or protein toxins, produced by the infectious agent. Peptides and nucleic acids are most commonly used as probes in biosensors because of their versatility in forming various tertiary structures. The interaction between the probe and the analyte can be detected by various sensor platforms, including quartz crystal microbalances, surface acoustical waves, surface plasmon resonance, amperometrics, and magnetoelastics. The field of biosensors is constantly evolving to develop devices that have higher sensitivity and specificity, and are smaller, portable, and cost-effective. This mini review discusses recent advances in peptide-dependent rapid biosensors and their applications as well as relative advantages and disadvantages of each technology.


Asunto(s)
Técnicas Biosensibles/métodos , Bioterrorismo , Técnicas de Sonda Molecular , Animales , Técnicas Biosensibles/economía , Humanos , Técnicas de Sonda Molecular/economía , Péptidos/genética , Péptidos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA